Selected research
Industry Research
Drugs For Travelers' Diarrhea (TD) Industry Research Report 2026
Market perspective
The global Drugs For Travelers' Diarrhea (TD) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drugs For Travelers' Diarrhea (TD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drugs For Travelers' Diarrhea (TD) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drugs For Travelers' Diarrhea (TD) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drugs For Travelers' Diarrhea (TD) include Sun Pharmaceutical Industries Ltd., Johnson & Johnson, Bayer AG, Valneva SE, Perrigo Company Plc, Norgine, Immuron, COSMO PHARMACEUTICALS and Bausch Health Companies Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drugs For Travelers' Diarrhea (TD) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drugs For Travelers' Diarrhea (TD) Market by Company
Sun Pharmaceutical Industries Ltd.
Johnson & Johnson
Bayer AG
Valneva SE
Perrigo Company Plc
Norgine
Immuron
COSMO PHARMACEUTICALS
Bausch Health Companies Inc.
Drugs For Travelers' Diarrhea (TD) Segment by Type
Antidiarrheal Agents
Oral Rehydration Therapy (ORS)
Antibiotics
Others
Drugs For Travelers' Diarrhea (TD) Segment by Application
Adults
Children
Drugs For Travelers' Diarrhea (TD) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs For Travelers' Diarrhea (TD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs For Travelers' Diarrhea (TD) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs For Travelers' Diarrhea (TD).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drugs For Travelers' Diarrhea (TD) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drugs For Travelers' Diarrhea (TD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antidiarrheal Agents
- Oral Rehydration Therapy (ORS)
- Antibiotics
- Others
Applications
- Adults
- Children
Companies covered
- Sun Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Bayer AG
- Valneva SE
- Perrigo Company Plc
- Norgine
- Immuron
- COSMO PHARMACEUTICALS
- Bausch Health Companies Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drugs For Travelers' Diarrhea (TD) Market Size (2021-2032)
- 2.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales (2021-2032)
- 2.2.3 Global Drugs For Travelers' Diarrhea (TD) Market Average Price (2021-2032)
- 2.3 Drugs For Travelers' Diarrhea (TD) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Antidiarrheal Agents
- 2.3.3 Oral Rehydration Therapy (ORS)
- 2.3.4 Antibiotics
- 2.3.5 Others
- 2.4 Drugs For Travelers' Diarrhea (TD) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drugs For Travelers' Diarrhea (TD) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drugs For Travelers' Diarrhea (TD) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Drugs For Travelers' Diarrhea (TD) Revenue of Manufacturers (2021-2026)
- 3.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Manufacturers (2021-2026)
- 3.5 Global Drugs For Travelers' Diarrhea (TD) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drugs For Travelers' Diarrhea (TD), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drugs For Travelers' Diarrhea (TD), Product Type & Application
- 3.8 Global Manufacturers of Drugs For Travelers' Diarrhea (TD), Established Date
- 3.9 Global Drugs For Travelers' Diarrhea (TD) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sun Pharmaceutical Industries Ltd.
- 4.1.1 Sun Pharmaceutical Industries Ltd. Company Information
- 4.1.2 Sun Pharmaceutical Industries Ltd. Business Overview
- 4.1.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.1.5 Sun Pharmaceutical Industries Ltd. Recent Developments
- 4.2 Johnson & Johnson
- 4.2.1 Johnson & Johnson Company Information
- 4.2.2 Johnson & Johnson Business Overview
- 4.2.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.2.5 Johnson & Johnson Recent Developments
- 4.3 Bayer AG
- 4.3.1 Bayer AG Company Information
- 4.3.2 Bayer AG Business Overview
- 4.3.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.3.5 Bayer AG Recent Developments
- 4.4 Valneva SE
- 4.4.1 Valneva SE Company Information
- 4.4.2 Valneva SE Business Overview
- 4.4.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.4.5 Valneva SE Recent Developments
- 4.5 Perrigo Company Plc
- 4.5.1 Perrigo Company Plc Company Information
- 4.5.2 Perrigo Company Plc Business Overview
- 4.5.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.5.5 Perrigo Company Plc Recent Developments
- 4.6 Norgine
- 4.6.1 Norgine Company Information
- 4.6.2 Norgine Business Overview
- 4.6.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.6.5 Norgine Recent Developments
- 4.7 Immuron
- 4.7.1 Immuron Company Information
- 4.7.2 Immuron Business Overview
- 4.7.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.7.5 Immuron Recent Developments
- 4.8 COSMO PHARMACEUTICALS
- 4.8.1 COSMO PHARMACEUTICALS Company Information
- 4.8.2 COSMO PHARMACEUTICALS Business Overview
- 4.8.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.8.5 COSMO PHARMACEUTICALS Recent Developments
- 4.9 Bausch Health Companies Inc.
- 4.9.1 Bausch Health Companies Inc. Company Information
- 4.9.2 Bausch Health Companies Inc. Business Overview
- 4.9.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Portfolio
- 4.9.5 Bausch Health Companies Inc. Recent Developments
5 Global Drugs For Travelers' Diarrhea (TD) Market Scenario by Region
- 5.1 Global Drugs For Travelers' Diarrhea (TD) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021-2032
- 5.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2021-2026
- 5.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales by Region: 2027-2032
- 5.3 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region: 2021-2032
- 5.3.1 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region: 2021-2026
- 5.3.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Region: 2027-2032
- 5.4 North America Drugs For Travelers' Diarrhea (TD) Market Facts & Figures by Country
- 5.4.1 North America Drugs For Travelers' Diarrhea (TD) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
- 5.4.3 North America Drugs For Travelers' Diarrhea (TD) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Drugs For Travelers' Diarrhea (TD) Market Facts & Figures by Country
- 5.5.1 Europe Drugs For Travelers' Diarrhea (TD) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
- 5.5.3 Europe Drugs For Travelers' Diarrhea (TD) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Drugs For Travelers' Diarrhea (TD) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drugs For Travelers' Diarrhea (TD) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drugs For Travelers' Diarrhea (TD) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drugs For Travelers' Diarrhea (TD) Market Facts & Figures by Country
- 5.7.1 South America Drugs For Travelers' Diarrhea (TD) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
- 5.7.3 South America Drugs For Travelers' Diarrhea (TD) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drugs For Travelers' Diarrhea (TD) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021-2032)
- 6.1.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Type (2021-2032)
- 6.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Type (2021-2032)
- 6.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Type (2021-2032)
- 6.3 Global Drugs For Travelers' Diarrhea (TD) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021-2032)
- 7.1.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Drugs For Travelers' Diarrhea (TD) Sales Market Share by Application (2021-2032)
- 7.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Application (2021-2032)
- 7.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Application (2021-2032)
- 7.3 Global Drugs For Travelers' Diarrhea (TD) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drugs For Travelers' Diarrhea (TD) Value Chain Analysis
- 8.1.1 Drugs For Travelers' Diarrhea (TD) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drugs For Travelers' Diarrhea (TD) Production Mode & Process
- 8.2 Drugs For Travelers' Diarrhea (TD) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drugs For Travelers' Diarrhea (TD) Distributors
- 8.2.3 Drugs For Travelers' Diarrhea (TD) Customers
9 Global Drugs For Travelers' Diarrhea (TD) Analyzing Market Dynamics
- 9.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
- 9.2 Drugs For Travelers' Diarrhea (TD) Industry Drivers
- 9.3 Drugs For Travelers' Diarrhea (TD) Industry Opportunities and Challenges
- 9.4 Drugs For Travelers' Diarrhea (TD) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst